Oral Contraceptives and Cardiovascular Risk: Adding Clinical Evidence to the Pathophysiology-Reference-Cited by-同舟云学术

Oral Contraceptives and Cardiovascular Risk: Adding Clinical Evidence to the Pathophysiology

Published:2020 Issue:3 Volume:33 Page:215-216
ISSN:2359-4802
Container-title:International Journal of Cardiovascular Sciences
language:en
Short-container-title:

Author:

Kasal Daniel Arthur B^ORCID,Lorenzo Andrea De^ORCID

Publisher

Sociedade Brasileira de Cardiologia

Link

https://www.scielo.br/pdf/ijcs/v33n3/2359-4802-ijcs-33-03-0215.pdf

Reference10 articles.

1. 1. Brasil. Ministério da Saúde. Saúde Brasil 2018 uma análise de situação de saúde e das doenças e agravos crônicos: desafios e perspectivas. Brasília; 2019.

2. Use and access to oral and injectable contraceptives in Brazil;Farias;Rev Saude Publica,2016

3. Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol;Torgrimson;Am J Physiol Heart Circ Physiol,2007

4. Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study;Lalude;Curr Cardiol Rep,2013

5. Contraceptive hormone use and cardiovascular disease;Shufelt;J Am Coll Cardiol,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical students' use of oral contraceptives: a viewpoint focusing on cardiovascular health;Jornal Brasileiro de Ginecologia;2023-02-01

2. A study of efficacy, safety, and acceptance of two combined oral contraceptive pills containing 150 mcg Levonorgestrel and 30 mcg Ethinyl Estradiol at Dr. Kariadi Hospital, Semarang, Indonesia;BALI MED J;2022

3. Arterial Stiffness and Hemodynamics in Young Women: The Effects of Oral Contraceptive Intake and Physical Habits;International Journal of Environmental Research and Public Health;2021-03-25